Rheumatology Network's Top 5: July 9, 2021
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending July 9, 2021.
Christopher Ritchlin, MD, MPH: Safety and Efficacy of Bimekizumab for Psoriatic Arthritis
Christopher Ritchlin, MD, MPH, discusses the safety and efficacy of bimekizumab in patients with psoriatic arthritis, the BE ACTIVE study, the clinical significance of these results, and his plans for future research on this topic.
Click the image to view the story.
Rheumatoid Arthritis Quiz: Initiating Methotrexate
Methotrexate has been the mainstay treatment for mild to moderate arthritis for many years, and the recent update to the American College of Rheumatology Guidelines on the Management of Rheumatoid Arthritis aims to maximize the use of methotrexate before advancing to a biologic or targeted synthetic disease-modifying antirheumatic drug (DMARD). With this in mind, it is important to be up-to-speed on initiating methotrexate in patients with rheumatoid arthritis. Test your knowledge with this quiz.
Click the image to view the story.
Teenage Zebras: Looking for Adolescent Depression in the Midst of Adaptive Teenage Angst
Chronic pain and functional limitations, along with these academic and social difficulties, are directly related to mental health complaints. Therefore, adolescents with rheumatic diseases are at a higher risk for developing mental illness.
Click the image to view the story.
Autoimmune Inflammatory Rheumatic Diseases, High-Dose Corticosteroids Linked to Poor COVID-19 Outcomes
Patients with autoimmune inflammatory rheumatic diseases had an increased risk of testing positive for SARS-CoV-2 and worse clinical outcomes of COVID-19, including death, although disease-modifying antirheumatic drugs (DMARDs) did not increase the risk of these outcomes.
Click the image to view the story.
Claire Daien, MD: ABX464 Treatment for Rheumatoid Arthritis
Claire Daien, MD, discusses the safety and efficacy of ABX464, the primary and secondary endpoints, and what differentiates the medication from other rheumatoid arthritis therapies.
Click the image to view the story.
